CAUSEY CHRISTOPHER 4
4 · UNITED THERAPEUTICS Corp · Filed Jan 5, 2026
Insider Transaction Report
Form 4
CAUSEY CHRISTOPHER
Director
Transactions
- Exercise/Conversion
Common Stock
2026-01-02$119.76/sh+1,000$119,760→ 5,190 total - Sale
Common Stock
2026-01-02$500.01/sh−1,000$500,015→ 4,190 total - Exercise/Conversion
Stock Option
2026-01-02−1,000→ 8,320 totalExercise: $119.76From: 2021-06-26Exp: 2030-06-26→ Common Stock (1,000 underlying)
Footnotes (2)
- [F1]This exercise of stock options and subsequent sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on September 30, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $500.00 to $500.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.